Denisenko Tatiana V, Gogvadze Vladimir, Zhivotovsky Boris
MV Lomonosov Moscow State University, 119991, Moscow, Russia.
Institute of Environmental Medicine, Division of Toxicology, Karolinska Institutet, Box 210, 171 77, Stockholm, Sweden.
Discov Oncol. 2021 Dec 1;12(1):58. doi: 10.1007/s12672-021-00454-1.
In order to maintain a functional mitochondrial network, cells have developed a quality control mechanism, namely mitophagy. This process can be induced through different pathways. The most studied is the so-called PINK1/Parkin pathway, which is associated with ubiquitylation of several mitochondrial proteins that were initially found to be related to Parkinson's disease. Another type of mitophagy is known as receptor-mediated mitophagy, which includes proteins, such as BNIP3 and BNIP3L, also known as Nix. Through these two mechanisms, mitophagy fulfills its functions and maintains cellular homeostasis. Here, we summarize the current knowledge about the mechanisms of mitophagy regulation and their interplay with cancer progression as well as anticancer treatment.
为了维持功能性线粒体网络,细胞已发展出一种质量控制机制,即线粒体自噬。这个过程可以通过不同途径诱导。研究最多的是所谓的PINK1/帕金通路,它与几种线粒体蛋白的泛素化有关,这些蛋白最初被发现与帕金森病有关。另一种类型的线粒体自噬被称为受体介导的线粒体自噬,它包括一些蛋白质,如BNIP3和BNIP3L(也称为Nix)。通过这两种机制,线粒体自噬发挥其功能并维持细胞内稳态。在这里,我们总结了目前关于线粒体自噬调控机制及其与癌症进展以及抗癌治疗相互作用的知识。